MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • Christophe LACOUR

    AIDES

    France

  • Cisneros Sierra Guido Vinicio

    Unidad De Salud Trans de la Direcciòn Provincial de Salud de Pichincha

    Ecuador

  • Cisneros Sierra Guido Vinicio

    Unidad De Salud Trans de la Direcciòn Provincial de Salud de Pichincha

    Ecuador

  • clarinda mancini maria

    paciente

    Brazil

  • Clayden Polly

    HIV i-Base

    United Kingdom

  • Clement Ferrazzano Maria José

    FEAT

    Spain

  • Clementson Glenda

    mission australia

    Australia

  • Cogger Shelley

    Burnet Institute

    Australia

  • Collazo Carlos

    Self

    United States

  • Collus-Villanueva Delphine

    France

  • Colorado Francisca

    España

    Spain

  • colsenet virginie

    France

  • Conil Sylvain

    France

  • cortes maria

    France

  • cossie soler pilar

    omsida

    Spain

  • Costa Alberto

    Cape Verde

  • Counterman Margaret

    United States

  • coux dorothée

    MdM

    France

  • COUZIGOU PATRICE

    university bordeaux

    France

  • Cowling Nicola

    Anex

    Australia

  • Coyle Ellen

    United States

  • Craig Tom

    Act Up Paris

    France

  • Crawley Jen

    Legal Aid ACT

    Australia

  • Creixell Inés

    Spain

  • Cris Freling

    France

  • Crocock Don

    Canada

  • Crowley margaret

    Australia

  • cruz ana paula

    Brazil

  • Cuevas Susana

    Spain

  • Curtis Matt

    VOCAL New York

    United States

  • Cusi Juana

    FUNDHEPA

    Mexico

  • CYRIL JAUME

    Medecins du Monde

    France

  • Cárdenas Lagranja Guillermo

    Hospital Universitario Vall d'Hebron

    Spain

  • D'Esopo Allyson

    Human Race

    United States

  • D'Onofrio Ubiratã

    Grupo Otimismo

    Brazil

  • Dagdelen Azad

    Germany

  • daldine steve

    United States

  • Damstra Gerard

    OUT Well-Being

    South Africa

  • danelia nia

    union tanadgoma

    Georgia

  • Daniel HILT

    France

  • DA PENHA ALVES MARIA

    APOIADORA

    Brazil

  • DARBON Michel

    France

  • Darling, DDS Richard

    FAIR Foundation

    United States

  • Das Debashish

    I D U F

    India

  • da silva flor

    no

    Uruguay

  • Da Silva Glicério Fernandes

    Brazil

  • da Silva Menezes Roberto

    independente

    Brazil

  • daubeze lydie

    aucune

    France

  • daurat Stéphane

    France

  • Daust Greg

    United States